Intensive patent workshop  | KN 3194

How to draft, analyse and circumvent a formulation patent 05.11. - 06.11.2018 | Berlin, Germany

Veranstaltungsort

art'otel berlin mitte
Wallstrasse 70-73
10179 Berlin
Tel.:+49-30-240620
E-Mail:abmres@artotels.com

Kursprogramm zum Download

Zielgruppe

The workshop is primarily designed for pharmaceutical professionals working in drug product development who frequently encounter patent issues, either as inventors of novel formulations or manufacturing processes, or as developers of drug products in the face of substantial third-party IP whose infringement must be avoided. Moreover, the course will be useful for pharmaceutical experts engaged in technology scouting, drug delivery technology development, in-licensing activities and due diligences.

Typical roles of participants include:

  • Formulation development scientists/managers
  • Drug delivery technology scouts
  • Project leaders in (technical/pharmaceutical) drug product development
  • Liaison managers working at the interface of pharmaceutical development & IP
  • Pharmaceutical experts in licensing & due diligence teams

Zielsetzung

This hands-on training course was developed to enhance the patent skills of pharmaceutical professionals who already have a basic knowledge of patents and their role in the pharmaceutical industry. The main objective is to convey advanced practical patent know-how with particular relevance for IP issues regularly occurring in drug product development. The successful participant will be enabled to immediately apply the acquired skills, provide high-quality input to project teams and decision-makers, avoid common pitfalls, and collaborate effectively with inhouse or external patent attorneys. 

In particular, the successful participant will be able to:

  • Effectively communicate the technical details of potential inventions and contribute to the evaluation of their patentability 
  • Provide and/or review high-quality draft patent applications or invention disclosures
  • Support the prosecution of patent applications by providing the responsible IP experts with useful technical insights
  • Provide correct and relevant input to enable patent search experts to perform meaningful prior art and freedom-to-operate patent searches
  • Collaborate with IP experts in interpreting the claims of third party patents and developing viable circumvention options
  • Contribute to freedom-to-operate analyses by providing relevant technical expertise based on a solid understanding of the underlying IP issues

Kooperationspartner

Pharma Patents International AG

Referenten

Karsten Cremer, PhD

Karsten Cremer, PhD, brings in the ideal expertise for leading this patent course. He is a European patent attorney and a pharmaceutical scientist with 20 years of professional experience in the field of drug delivery. Through his intimate knowledge from both sides of the fence, he has become a successful trainer for pharmaceutical professionals who tackle patent challenges relating to drug products, dosage form designs, formulations, kits, and manufacturing methods.
Karsten is the founder and managing director of Pharma Concepts GmbH, a pharmaceutical IP consultancy located in Basel (Switzerland). In previous pointments, he was CEO of Capsulution Nano Science AG, Director of Oral Drug Delivery at LTS Lohmann Therapy Systems, and Lecturer of Pharmaceutics at the University of Marburg. As a pharmaceutical IP expert, Karsten works with large pharmaceutical companies as well as small and medium-size drug delivery companies.
His specialities include IP issues relating to pharmaceutical formulations and drug delivery technologies. In addition to drafting, filing and prosecuting patent applications, he is experienced in opposing and defending patents, developing and implementing tailor-made patent strategies, managing patent portfolios, establishing patent landscapes, performing freedom-to-operate  analyses, and conducting technical and IP due diligences.
Karsten is an experienced speaker and tutor with a proven track record of success within the APV and other professional organisations. He is also founder and member of the APV Drug Delivery Focus Group.

Kurt Schellhaas, PhD

Kurt Schellhaas, PhD, joined Pharma Concepts in 2016 as a Senior Associate on the basis of more than 15 years of professional experience in academia and industry. He completed his studies in Chemistry at J. W. Goethe University, Frankfurt and holds a Ph.D. in Organic Chemistry from Technical University Berlin. After his postdoctoral studies at the Scripps Institution of Oceanography
at the University of California, La Jolla he joined BASF SE as a medicinal chemist. In 2002, Kurt decided to focus his professional career on the field of Intellectual Property and joined the BASF Global IP department where he worked as a European Patent Attorney and Senior Patent Counsel in the field of vitamins and precursors thereof, APIs and pharmaceutical intermediates as well as aroma chemicals covering a broad range of technologies from lab to world scale applications.
In 2009, Kurt joined Roche Diagnostics broadening his area of IP practice to consumer medical technology and devices in the area of Diabetes Care as a Senior Counsel and ultimately as Head of Patents Diabetes Care.
As Karsten, Kurt brings in relevant hands-on experience in the management of the multiple interfaces between internal and external R&D units, IP departments as well as other relevant stakeholders in the pharmaceutical industry as well as related technical areas.

Preise

  Kategoriepreis
Industry 1.490,00 €
Authorities/University 745,00 €
Students/full time 178,00 €
Alle Preise zzgl. VAT

Veranstalter

APV GmbH

Tel.: +49 6131 97690
Fax: +49 6131 976969
E-Mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/apv/